Home 2024
Archives
The role of stem cell-derived tissues in novel treatments for cardiac ailments
Curbs on animal testing mean human tissues derived from induced pluripotent stem cells offer a promising platform in discovering novel treatments for cardiac ailments.
BRAV3 Project: Cardiac regenerative medicine
Prof Felipe Prósper, Head of Department, and Dr Manuel Mazo, from the University of Navarra & Clínica Universidad de Navarra, shares his expertise in cardiovascular diseases, focusing on the work of the BRAV3 project, which includes research in cardiac regenerative medicine.
Cigarette smoking focus: A modeling approach for estimating the impact of health programs
Theodore R. Holford from Yale University charts a modeling approach for estimating the impact of health programs in this cigarette smoking research focus.
Treating neuropathic pain and nicotine dependence: Epibatidine derivatives as potential therapeutics
Lance R. McMahon, Ph.D. and Jenny L. Wilkerson, Ph.D. from Texas Tech University Health Sciences Center, describe the search for the magic bullet to treat both neuropathic pain and nicotine dependence using novel epibatidine derivatives as potential therapeutics.
Tackling physical inactivity and a sedentary lifestyle: Two distinct approaches
Being physically inactive and sedentary are two distinct issues that affect older adults. However, each problem necessitates a unique set of solutions; Professor Isabelle J. Dionne from the Université de Sherbrooke tells us more.
Enhancing marathon safety: The role of low-dose aspirin in cardiac arrest prevention
Arthur J. Siegel, Medical Director at MGH Internal Medicine Associates, Belmont, MA, USA tells us how low-dose aspirin can support primary prevention of marathon-related cardiac arrest in middle-aged men with coronary atherosclerosis.
Age-related changes in cardiomyopathic phenotype in patients with barth syndrome
With current treatment options for BTHS cardiomyopathic phenotype focused predominantly on alleviating symptoms, Dr Hani N. Sabbah, Director of Cardiovascular Research at Henry Ford Health, explores the potential of more targeted treatment approaches.